Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study
2016 ◽
Vol 13
(2-3)
◽
pp. 187-196
◽
2018 ◽
Vol 25
(2)
◽
pp. 118-129
◽
2020 ◽
2020 ◽
Rosiglitazone increases high-density lipoprotein cholesterol levels in patients with type 2 diabetes
2003 ◽
Vol 41
(6)
◽
pp. 316
◽
2010 ◽
Vol 19
(1)
◽
pp. 15-22
◽
Keyword(s):
2014 ◽
Vol 12
(1)
◽
pp. 25-30
◽